E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/12/2007 in the Prospect News Special Situations Daily.

SAC Capital reduces stake in Bausch & Lomb

By Lisa Kerner

Charlotte, N.C., July 12 - Bausch & Lomb Inc. investors led by SAC Capital Advisors, LLC sold 1,323,918 shares of the company's stock between July 5 and July 11, priced between $67.83 and $72.25 per share, according to a schedule 13D filing with the Securities and Exchange Commission.

The reporting persons beneficially own 1,458,597 shares, or 2.7%, of the Rochester, N.Y., eye health products company.

On July 5, SAC Capital reported a 5.5% stake in Bausch & Lomb following the purchase of 2,989,995 shares of the company's stock for $202.57 million.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.